Email Updates

You are here

Home

CDC 494

Status
Completed
Phase
Open Label
Principal Investigator(s)
Botswana Ministry of Health, CDC, Gilead
Objective

Follow-on trial of daily oral TDF/FTC in heterosexual men and women.

 

**Results presented in July 2015 show strong adherence, high drug levels and no HIV infections and support efforts to expand PrEP availability in the context of generalized epidemics in resource-limited settings.**

Prevention Option(s)
PrEP
Trial Sponsors
Botswana Ministry of Health, CDC, Gilead
Product Developers
Botswana Ministry of Health, CDC, Gilead
18
Years
Population
Women
Men
Sites

Site(s) - Botswana

Botswana